Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 759 results found. Search for [ Indian pharma companies in US ]

Results 100 to 120 of 759
PTI
December 13, 2018



BusinessToday.In
new Delhi, December 11, 2018
The BSE SENSEX closed at 35,150.01, up by 190.29 points, or by 0.54 per cent and the NSE Nifty ended higher by 60.70 points, or 0.58 per cent, at 10,549.15.


PTI
December 7, 2018



PTI
November 27, 2018



PTI
November 26, 2018



PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


E Kumar Sharma
New Delhi, November 26, 2018
Teva, Mylan, and even India's biggest, Sun Pharma, are opting out of products that aren't commercially viable.


PTI
November 22, 2018
According to analysts, market failed to hold the opening gains as weak global market and selling in metals and PSU banks dragged the indices. Global growth concerns due to trade war, rising interest rate and lower liquidity in the financial markets added to the woes, analysts said.


PTI
November 22, 2018



E Kumar Sharma
New Delhi, November 21, 2018
Some of the leading Indian pharma companies are pitching in to cater to the markets that some of the big pharma companies are vacating as part of their product optimisation strategies.


Renu Yadav
November 20, 2018
The fund house believes that these are interesting times for Indian healthcare sector despite disappointing earnings in FY18. The sector has the potential to get re-rated after temporary disruptions get resolved


PTI
November 20, 2018



PTI
November 15, 2018



E Kumar Sharma
November 13, 2018
At the moment most experts are in a wait and watch mode, while some players from these sectors think that it could be a mixed bag.


PTI
November 2, 2018



BusinessToday.In
October 31, 2018
The brokerage is concerned about patchy monsoon, election season, rising twin deficits, high crude prices, weak INR, slowing Chinese economy, trade wars, etc.  It wonders whether the market will recover at all or whether a bear market is the next phase?


PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


PTI
October 28, 2018



BusinessToday.In
New Delhi, October 17, 2018
Forbes' best employer in the world list also includes Mahindra & Mahindra (rank 55), Grasim Industries (59) and HDFC (91).


PTI
October 15, 2018



PAGES 6 OF 38  678910